Conjugated anti-CD38 antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9676869
SERIAL NO

14754592

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITED1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA 5410045 ?5410045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhaskar, Vinay South San Francisco, US 45 425
Drake, Andrew Walling South San Francisco, US 12 119
Elias, Kathleen Ann San Francisco, US 13 117
Haak-Frendscho, Mary San Francisco, US 55 742
Korver, Wouter South San Francisco, US 33 301
Landes, Gregory San Bruno, US 19 258
Singh, Shweta South San Francisco, US 38 350
Snell, Gyorgy Pal San Francisco, US 10 114

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00